Clinical Trial Update: The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive [NA]

View source ↗

Summary

This entry describes a real-world study evaluating Pyrotinib for advanced HER2-positive breast cancer, with the trial status listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Breast Cancer, RWS | NA | Status: NOT_YET_RECRUITING